市場調查報告書
商品編碼
1236070
冷鏈包裝全球市場規模研究與預測,按產品類型(EPS 容器、PUR 容器、托盤托運人、真空隔熱板等),按應用(製藥、食品、工業),區域分析,2022-2029 年Global Cold Chain Packaging Market Size study & Forecast, by Product Type (EPS Containers, PUR Containers, Pallet Shippers, Vacuum Insulated Panels, Others), by Application (Pharmaceuticals, Food, Industrial) and Regional Analysis, 2022-2029 |
2021 年全球冷鏈包裝市場價值約為 208.9 億美元,預計在 2022-2029 年預測期內將以超過 10.9% 的健康增長率增長。
冷鏈包裝是涉及貨物包裝和運輸的各種系統,需要將其保持在特定溫度下以保持和保持質量和功效。 這種包裝有助於將藥品、食品和工業產品等商品保持在合適的溫度下。 對有效包裝解決方案的需求不斷增長,新興國家的快速城市化以及對加工即食食品的需求不斷增加是推動全球市場需求的主要因素。。
冷鏈包裝市場的擴張在很大程度上是由製藥行業推動的,因為對溫度敏感的貨物的運輸需求不斷增長。 藥品包裝由真空絕緣板、盒子、容器、托盤托運人和板條箱組成,用於儲存免疫、輸液和注射劑、生物製劑、激素、胰島素、抗生素、細胞治療藥物、試劑和其他治療藥物。 因此,對特殊熱包裝和運輸系統以保持產品質量的需求不斷增加。 根據 IQVIA 的 Pharmaceutical Commerce Analysis,2018 年約有 18% 的藥品預算用於冷鏈,包括消耗品和運輸。 在製藥業務中,冷鏈解決方案的增長速度是非冷鏈解決方案的兩倍。 此外,據報導,生物製藥產品的銷售額已從 2019 年的 2660 億美元增至 2020 年的 2840 億美元。 因此,這些高價值藥品通常在冷鏈的幫助下分佈在全球分銷網絡中,從而以顯著的速度推動市場增長。 此外,增加對先進技術開發的投資和對可持續包裝的日益關注在預測期內提供了各種有利可圖的機會。 然而,所需的高初始成本和復雜監管框架的存在正在影響整個 2022-2029 年預測期內的市場增長。
冷鏈包裝全球市場研究中考慮的主要區域是亞太地區、北美、歐洲、拉丁美洲和世界其他地區。 由於對新鮮和有機食品消費的日益偏好以及許多市場進入者的存在,北美在銷售方面佔據了市場主導地位。 另一方面,由於技術發展的進步和對藥品的需求不斷增長等因素,預計亞太地區在預測期內將以最高的複合年增長率增長。
本研究的目的是弄清近年來各個領域和國家的市場規模,並對未來幾年的市場規模進行預測。 該報告旨在捕捉被調查國家工業的定性和定量方面的情況。
它還提供了關鍵方面的詳細信息,例如決定市場未來增長的驅動因素和挑戰。 此外,它還結合了利益相關者投資的潛在微觀市場機會,以及主要參與者的競爭格局等詳細分析。
Global Cold Chain Packaging Market is valued at approximately USD 20.89 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 10.9% over the forecast period 2022-2029. Cold chain packaging is a variety of systems that includes packaging and shipping of goods that need to be stored at a specific temperature to preserve and maintain their quality and effectiveness. This packaging helps in storing goods such as pharmaceuticals, food, and industrial at a suitable temperature. The surging demand for effective packaging solutions, rapid urbanization in emerging economies, coupled with the increasing demand for processed and easy-to-eat food items are the key factors that are fostering market demand across the world.
The expansion of the cold chain packaging market is primarily influenced by the pharmaceutical industry owing to the rising need for transporting temperature-sensitive goods. The pharmaceutical packaging comprises vacuum-insulated panels, boxes, containers, pallet shippers, and crates, which are used to store vaccinations, infusions/injections, biologics, hormones, insulin, antibiotics, cellular therapies, reagents, and other treatment alternatives. Accordingly, a growing requirement for specialized thermal packing and transportation systems to maintain product quality. According to the Pharmaceutical Commerce Analysis of IQVIA, in 2018, approximately 18% of the total pharma budget is spent on the cold chain, which includes supplies and transportation. In the pharmaceutical business, the growth of cold chain solutions is increasing 2 times faster than that of non-cold chain solutions. Moreover, also reported that the sales of biotechnology drugs products rose to USD 284 billion in 2020 from USD 266 billion in 2019. Consequently, these high-value medicinal items are typically distributed throughout the whole global distribution network with the help of the cold chain, which, in turn, augments the market growth at a substantial rate. Moreover, rising investment in the development of advanced technology, as well as the growing focus on sustainable packaging are presenting various lucrative opportunities over the forecasting years. However, the high initial costs required and the presence of a complex regulatory framework are challenging the market growth throughout the forecast period of 2022-2029.
The key regions considered for the Global Cold Chain Packaging Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America dominated the market in terms of revenue, owing to the rising preference towards the intake of fresh and organic food, along with the high presence of a large number of major industry participants. Whereas, the Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as rising technological developments and high demand for medicines in the market space.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
List of figures
List of tables and figures and dummy in nature, final lists may vary in the final deliverable